The management team of Arctic Aurora LifeScience share their thoughts of the latest development in the pharmaceuticals and biotech sector as well as the performance of the fund and some of the portfolio companies. M&A activity has increased during August and September. The portfolio companies that has been acquired are being discussed. Looking forward, the outlook for vaccines for Covid-19 among others subjects are discussed at the end of the video.
